|
|
|
Remote ECG Screening |
| |
CompuMed,
Inc. Announces New Contract with Wexford Health Sources to
Provide Remote ECG Screening to Correctional Sites in
Mississippi
Other Topics: Medical
Informatics Engineering,
Electronic Health Record (EHR) Solution,
Telemedicine Healthcare
CompuMed
October 17, 2006
CompuMed, Inc., a medical informatics company serving the
healthcare community and leading the development of advanced
imaging and medical informatics to provide cost-effective
analysis and monitoring -- today announced three agreements that
extend its dominance as the leading provider of
electrocardiogram (ECG) remote interpretation systems and
services for correctional institutions.
The agreements include a new three-year statewide contract in
conjunction with Wexford Health Sources, Inc. to provide
electrocardiogram (ECG) remote interpretation systems and
services for the Mississippi Department of Corrections. Under
the terms of the agreement, CompuMed's CardioGram system will
perform remote cardiac screening for detainees at two of the
state's main correctional facilities as well as at 11 County
Regional facilities. CompuMed is a preferred value-added partner
of Pittsburgh-based Wexford Health Sources, which provides
comprehensive healthcare services for correctional system
clients nationwide. CompuMed now services Wexford facilities in
three states. |
| |
|
|
| |
"We are pleased
to further expand our successful partnership with Wexford Health
Sources," said Jerry McLaughlin, CompuMed's CEO. "Providing
quality healthcare services for correctional facilities while
containing costs is a challenge, especially given the aging
prison population. We look forward to helping correctional
clients continue to meet this challenge with additional services
in the future."
In addition to the new Mississippi/Wexford contract, CompuMed
renewed contracts with state correctional clients in Oklahoma
and Texas. Under the terms of the Oklahoma Department of
Corrections (OKDOC) contract extension, CompuMed will provide
remote cardiac screening on an as-needed basis for more than
14,000 detainees at all 20 of the Department's facilities. Under
the terms of the new two-year Texas Tech University Health
Sciences Center agreement, CompuMed will provide interpretative
ECG services to 10 correctional facilities. These three
agreements are estimated to total more than $143,000 in annual
revenue.
"We are pleased that our state correctional partners continue to
renew their agreements with CompuMed," Jerry McLaughlin added.
"Our ECG business is a recurring revenue model. Providing these
types of services is a competency that we plan to leverage and
expand in the coming months in concert with our complementary
analysis technology."
The CompuMed system significantly reduces healthcare costs by
providing remote cardiac screening at the point of care. Another
key advantage is an optional feature that automatically sends
ECG results to a trained cardiologist for an over-read when the
results are abnormal.
About CompuMed
CompuMed, Inc. (OTCBB:CMPD) is leading the development of
advanced imaging and medical informatics to provide
cost-effective analysis and monitoring solutions. The Company
focuses on cardiovascular and muscular skeletal diseases and
other diseases associated with aging populations. The Company
has unique expertise in telemonitoring, imaging and analysis
which it is deploying to provide solutions and services designed
to improve the workflow of healthcare providers, improve
patient's care and reduce costs. The Company's core products are
the OsteoGram(R) and CardioGram systems. The OsteoGram, which is
cleared by the FDA for commercial use, is an accurate and
precise technology for cost-effective osteoporosis testing. The
CardioGram system remotely interprets electrocardiograms and is
used by private practice, government and corporate healthcare
providers nationwide. CompuMed is headquartered in Los Angeles.
Visit CompuMed at www.compumed.net or call 310-258-5000.
This news release contains forward-looking statements as defined
by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning
CompuMed's plans, objectives, goals, strategies, future events
or performance and underlying assumptions and other statements
that are not statements of historical fact. These statements are
subject to uncertainties and risks including, but not limited
to, product and service demand and acceptance, changes in
technology, ability to raise capital, the availability of
appropriate acquisition candidates and/or business partnerships,
economic conditions, the impact of competition and pricing,
capacity and supply constraints or difficulties, government
regulation and other risks identified in the Company's filings
with the Securities and Exchange Commission. All such
forward-looking statements are expressly qualified by these
cautionary statements. In addition, the Company disclaims any
obligation to update any forward-looking statements to reflect
events or circumstances after the date hereof, except as
required by law. |
| |
|
|
| |
|
|
